<DOC>
	<DOCNO>NCT00986531</DOCNO>
	<brief_summary>The purpose study assess AZD8529 improve performance neurobehavioral probe attention , work memory affective reactivity patient schizophrenia .</brief_summary>
	<brief_title>The Effects AZD8529 Cognition Negative Symptoms Schizophrenics</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>DSMIV diagnosis schizophrenia schizoaffective disorder ECT last 6 month Substance abuse dependence History claustrophobia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>early phase trial</keyword>
</DOC>